SD Biosensor, Inc. (KRX:137310)

South Korea · Delayed Price · Currency is KRW

8,320.00

-120.00 (-1.42%)

Mar 3, 2026, 9:00 AM KST

-23.32% (1Y)

Market Cap	1.01T
Revenue (ttm)	696.13B
Net Income (ttm)	113.22B
Shares Out	119.62M
EPS (ttm)	941.16
PE Ratio	8.97
Forward PE	n/a
Dividend	200.00 (2.37%)
Ex-Dividend Date	Mar 30, 2026

Volume	8,599
Average Volume	175,646
Open	8,280.00
Previous Close	8,440.00
Day's Range	8,250.00 - 8,340.00
52-Week Range	8,150.00 - 13,550.00
Beta	0.80
RSI	39.64
Earnings Date	Feb 20, 2026

About SD Biosensor

SD Biosensor, Inc., together with its subsidiaries, operates as an in-vitro diagnostic company in South Korea, India, Asia, Europe, the Americas, and Africa. The company offers STANDARD Q, which provides rapid diagnostic products; STANDARD F, a fluorescence immunodiagnostic system for various qualitative and quantitative diagnosis items; STANDARD E, an enzyme immunoassay diagnosis for large-volume tests; and STANDARD M, a field molecular diagnosis system for infectious disease diagnosis, drug resistance, and genetic testing. It also provides ST... [Read more]

Industry Medical Instruments & Supplies

Sector Healthcare

Founded 1999

Employees 576

Stock Exchange Korea Stock Exchange

Ticker Symbol 137310

Full Company Profile

Financial Performance

In 2024, SD Biosensor's revenue was 694.57 billion, an increase of 5.93% compared to the previous year's 655.68 billion. Losses were -98.41 billion, -78.96% less than in 2023.

Financial Statements

News

There is no news available yet.